Elekta (OTCMKTS:EKTAY) Shares Gap Down – Here’s Why

Shares of Elekta AB (OTCMKTS:EKTAY) gapped down before the market opened on Thursday . The stock had previously closed at $5.8650, but opened at $5.53. Elekta shares last traded at $5.53, with a volume of 108 shares traded.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 28th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Reduce”.

Elekta Price Performance

The company’s fifty day moving average is $5.18 and its 200 day moving average is $5.71. The firm has a market cap of $2.03 billion, a price-to-earnings ratio of -34.38 and a beta of 1.01. The company has a quick ratio of 0.68, a current ratio of 0.87 and a debt-to-equity ratio of 0.47.

Elekta (OTCMKTS:EKTAY) last issued its quarterly earnings results on Thursday, August 27th. The company reported $0.07 earnings per share (EPS) for the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 11.11%. On average, equities research analysts predict that Elekta AB will post 0.43 EPS for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.